Topic: Amedisys Inc.

By David Sterman. It's an old investing axiom that you can make money when stocks are hated. The rule also applies to the broader stock market and...

What Investors Think About Amedisys

Together, we are all trying to build our fortunes by finding well-run companies at bargain-basement prices. But it takes work to scour earnings...

Is Amedisys Growing Foolishly?

I love a great growth company as much as the next stock junkie, but growth for growth's sake just doesn't cut it for me. I want to see a company...
The S&P 500's current trailing 12-month price-to-earnings ratio is 20.13, 101% higher than it was back in March when the markets hit bottom. In a...
Shares of Home Health Care stocks fall over SEC investigation into AmedisysShares of home health providers fell Thursday as the Securities and Exchange Commission formally opened an investigation into potential medicare billing fraud at Amedisys Inc. and
Shares of four home health care providers tumbled Thursday after the Senate Finance Committee raised questions about how the companies bill Medicare for home health therapy visits.The committee sent letters to Amedisys Inc., Almost Family Inc., Gentiva He

Lawmakers investigating home healthcare companies

WASHINGTON (Reuters) - The Senate Finance Committee is investigating four for-profit home healthcare agencies over billing practices lawmakers say raise questions about reimbursement from the Medicare insurance program.Shares of the companies -- Amedisys
<div id="subtitle">Amedisys declines after analyst says health care overhaul will slash company's profit in 2011Shares of home health provider Amedisys Inc. slipped Thursday after an analyst downgraded the stock, saying the health care overhaul bill
A First Analysis Securities Corp. analyst upgraded shares of Amedisys Inc. and LHC Group Inc. Monday, saying any health care reform changes to Medicare reimbursement will likely not have a significant impact on the companies.Baton Rouge, La.-based Amedisy
Analyst puts Amedisys on watch listExactly one year ago I wrote the following in Cabot Wealth Advisory on the subject of financial stocks: “On the surface, the problem appears confined to the sub-prime residential lending market; thus the calls to regu